title: Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good.
authors.forename: Athol U
authors.initials: AU
authors.lastname: Wells
authors.forename: Juergen
authors.initials: J
authors.lastname: Behr
authors.forename: Ulrich
authors.initials: U
authors.lastname: Costabel
authors.forename: Vincent
authors.initials: V
authors.lastname: Cottin
authors.forename: Venerino
authors.initials: V
authors.lastname: Poletti
authors.forename: Luca
authors.initials: L
authors.lastname: Richeldi
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D018450:Disease Progression; D023381:Endpoint Determination; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000175:diagnosis / Q000401:mortality* / Q000628:therapy*; D012107:Research Design; D016896:Treatment Outcome